Public Health Ontario and the Institute for Quality Management in Healthcare have released Antimicrobial Resistance in Common Hospital Pathogens in Ontario: Annual Laboratory and Hospital Survey Report 2016.
This annual survey allows us to monitor and compare trends in Ontario over time. This may also help to inform policy and practice changes at the provincial and local level.
The report includes information on the burden of antimicrobial-resistant organisms in healthcare, as well as laboratory screening practices, and hospital infection control practices. The key findings are: Based on data provided by laboratories, there was an overall decrease in patients colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) in 2016 compared to 2015.
Laboratories across the province reported a decrease in incident patients with a clinical (i.e., non-screening) isolate of VRE in 2016, compared to clinical VRE isolates in 2015. However, the proportion of VRE-infected patients with bacteremia has increased noticeably since 2013.
Laboratories reported consistent proportions of resistance among third-generation cephalosporins and ciprofloxacin in Escherichia coli and Klebsiella spp. isolates in 2016 compared to 2015.
Similar to 2015, New-Delhi metallo-beta-lactamase (NDM) mediated resistant Enterobacteriaceae were the most commonly isolated CPO in 2016.
With in-house C. difficile testing laboratories, 88.5% reported a turnaround time (TAT) of <24 hours from when the specimen is received to when the test result is reported.
Read the full report for more information on the results of this survey. We encourage you to share this report with any of your peers or colleagues who may be interested.